Discontinued — last reported Q4 '25
Edwards Lifesciences Change in Income Taxes increased by 510.8% to $41.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.2%, from $51.20M to $41.90M. Over 3 years (FY 2021 to FY 2024), Change in Income Taxes shows a downward trend with a 44.4% CAGR.
An increase in tax liabilities acts as a source of cash, while a decrease indicates cash outflows for tax settlements.
This metric tracks the net change in income tax liabilities or receivables resulting from timing differences between tax...
Standard across all industries; highly dependent on global tax jurisdictions and specific corporate tax planning strategies.
change_in_income_taxes| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.10M | $5.80M | $33.00M | $82.90M | -$33.20M | -$40.90M | -$14.40M | $87.20M | -$56.20M | $75.30M | -$112.10M | -$263.10M | -$106.90M | $671.80M | -$488.50M | $51.20M | -$240.40M | -$10.20M | $41.90M |
| QoQ Change | — | -36.3% | +469.0% | +151.2% | -140.0% | -23.2% | +64.8% | +705.6% | -164.4% | +234.0% | -248.9% | -134.7% | +59.4% | +728.4% | -172.7% | +110.5% | -569.5% | +95.8% | +510.8% |
| YoY Change | — | — | — | — | -464.8% | -805.2% | -143.6% | +5.2% | -69.3% | +284.1% | -678.5% | -401.7% | -90.2% | +792.2% | -335.8% | +119.5% | -124.9% | -101.5% | -18.2% |